BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20818659)

  • 21. SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
    Emelyanov A; Andoskin P; Yakimovskii A; Usenko T; Nuzhnyi E; Nikolaev M; Pchelina S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1064-5. PubMed ID: 23830801
    [No Abstract]   [Full Text] [Related]  

  • 22. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
    Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
    Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene.
    Antonini A; Pilleri M; Padoan A; Landi A; Ferla S; Biundo R; D'Avella D
    J Neurol; 2012 Jan; 259(1):165-7. PubMed ID: 21761143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of α-synuclein by SNCA duplication is associated with resistance to toxic stimuli.
    Kim HJ; Jeon BS; Yoon MY; Park SS; Lee KW
    J Mol Neurosci; 2012 Jun; 47(2):249-55. PubMed ID: 22392151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homozygous alpha-synuclein p.A53V in familial Parkinson's disease.
    Yoshino H; Hirano M; Stoessl AJ; Imamichi Y; Ikeda A; Li Y; Funayama M; Yamada I; Nakamura Y; Sossi V; Farrer MJ; Nishioka K; Hattori N
    Neurobiol Aging; 2017 Sep; 57():248.e7-248.e12. PubMed ID: 28666710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SNCA rs3822086 C>T Polymorphism Increases the Susceptibility to Parkinson's Disease in a Chinese Han Population.
    Jian CD; Huang JM; Meng LQ; Li XB; Huang RY; Shi SL; Wu Y; Qin C; Chen J; Zhang YM; Wang S; Feng YL; Zhou SN
    Genet Test Mol Biomarkers; 2015 Sep; 19(9):481-7. PubMed ID: 26203864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
    Ibáñez P; Bonnet AM; Débarges B; Lohmann E; Tison F; Pollak P; Agid Y; Dürr A; Brice A
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1169-71. PubMed ID: 15451225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients homozygous and heterozygous for SNCA duplication in a family with parkinsonism and dementia.
    Ikeuchi T; Kakita A; Shiga A; Kasuga K; Kaneko H; Tan CF; Idezuka J; Wakabayashi K; Onodera O; Iwatsubo T; Nishizawa M; Takahashi H; Ishikawa A
    Arch Neurol; 2008 Apr; 65(4):514-9. PubMed ID: 18413475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    Maraganore DM; de Andrade M; Elbaz A; Farrer MJ; Ioannidis JP; Krüger R; Rocca WA; Schneider NK; Lesnick TG; Lincoln SJ; Hulihan MM; Aasly JO; Ashizawa T; Chartier-Harlin MC; Checkoway H; Ferrarese C; Hadjigeorgiou G; Hattori N; Kawakami H; Lambert JC; Lynch T; Mellick GD; Papapetropoulos S; Parsian A; Quattrone A; Riess O; Tan EK; Van Broeckhoven C;
    JAMA; 2006 Aug; 296(6):661-70. PubMed ID: 16896109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease.
    Ross OA; Gosal D; Stone JT; Lincoln SJ; Heckman MG; Irvine GB; Johnston JA; Gibson JM; Farrer MJ; Lynch T
    Mech Ageing Dev; 2007; 128(5-6):378-82. PubMed ID: 17531291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
    Bozi M; Papadimitriou D; Antonellou R; Moraitou M; Maniati M; Vassilatis DK; Papageorgiou SG; Leonardos A; Tagaris G; Malamis G; Theofilopoulos D; Kamakari S; Stamboulis E; Hadjigeorgiou GM; Athanassiadou A; Michelakakis H; Papadimitriou A; Gasser T; Stefanis L
    Eur J Neurol; 2014 Jul; 21(7):963-8. PubMed ID: 24313877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.
    Ibáñez P; Lesage S; Janin S; Lohmann E; Durif F; Destée A; Bonnet AM; Brefel-Courbon C; Heath S; Zelenika D; Agid Y; Dürr A; Brice A;
    Arch Neurol; 2009 Jan; 66(1):102-8. PubMed ID: 19139307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical variability in Chinese families with Parkinson disease and SNCA duplication, including the shortest 139kb duplication.
    Du YJ; Shen Y; Wang YX; Sun YM; Liu FT; Chen C; Chen K; Zuo CT; Wu JJ; Wang J; An Y; Yu H
    Parkinsonism Relat Disord; 2019 Nov; 68():60-62. PubMed ID: 31621621
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.
    Fukusumi H; Togo K; Sumida M; Nakamori M; Obika S; Baba K; Shofuda T; Ito D; Okano H; Mochizuki H; Kanemura Y
    FEBS Open Bio; 2021 Feb; 11(2):354-366. PubMed ID: 33301617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.
    Miller DW; Hague SM; Clarimon J; Baptista M; Gwinn-Hardy K; Cookson MR; Singleton AB
    Neurology; 2004 May; 62(10):1835-8. PubMed ID: 15159488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha-Synuclein multiplication analysis in Italian familial Parkinson disease.
    Sironi F; Trotta L; Antonini A; Zini M; Ciccone R; Della Mina E; Meucci N; Sacilotto G; Primignani P; Brambilla T; Coviello DA; Pezzoli G; Goldwurm S
    Parkinsonism Relat Disord; 2010 Mar; 16(3):228-31. PubMed ID: 19833540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alpha-synuclein polymorphisms are associated with Parkinson's disease in a Saskatchewan population.
    Rajput A; Vilariño-Güell C; Rajput ML; Ross OA; Soto-Ortolaza AI; Lincoln SJ; Cobb SA; Heckman MG; Farrer MJ; Rajput A
    Mov Disord; 2009 Dec; 24(16):2411-4. PubMed ID: 19890971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population.
    Wei Y; Yang N; Xu Q; Sun Q; Guo J; Li K; Liu Z; Yan X; Zhu X; Tang B
    J Neurol Sci; 2016 Aug; 367():11-4. PubMed ID: 27423554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The many faces of alpha-synuclein mutations.
    Kasten M; Klein C
    Mov Disord; 2013 Jun; 28(6):697-701. PubMed ID: 23674458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.